Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
Sign Up to like & getrecommendations! Published in 2020 at "BMC Neurology"
DOI: 10.1186/s12883-020-01789-y
Abstract: Background A high multiple sclerosis activity while on alemtuzumab is rather uncommon compared to moderate-efficacy drugs. The purpose of this case report is to present a case of a 37-year-old female patient with bronchial asthma… read more here.
Keywords: active rrms; rrms ocrelizumab; highly active; alemtuzumab therapy ... See more keywords